These results may also partially explain why pancreatic cancer cells are sensitive to alizarin, since the earlier data (Fig. 2-Fig. 5) showed that alizarin can effectively reduce NF-κB activity. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.